HJ Research delivers in-depth insights on the global Adrenocortical Carcinoma Treatment market in its upcoming report titled, Global Adrenocortical Carcinoma Treatment Market Report 2018-2029. According to this study, the global Adrenocortical Carcinoma Treatment market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Adrenocortical Carcinoma Treatment market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Adrenocortical Carcinoma Treatment market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Adrenocortical Carcinoma Treatment industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Adrenocortical Carcinoma Treatment industry.
Global Adrenocortical Carcinoma Treatment market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Adrenocortical Carcinoma Treatment industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Adrenocortical Carcinoma Treatment market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Adrenocortical Carcinoma Treatment. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Adrenocortical Carcinoma Treatment market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Adrenocortical Carcinoma Treatment in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Adrenocortical Carcinoma Treatment market include:
ArQule
EnGeneIC
Exelixis
Merck
Millendo Therapeutics
Orphagen Pharmaceuticals
Market segmentation, by product types:
Localized Adrenocortical Carcinoma
Metastatic Adrenocortical Carcinoma
Market segmentation, by applications:
Hospitals
Ambulatory Surgical Centers
Clinics
Cancer Research Institutes
1 Industry Overview of Adrenocortical Carcinoma Treatment
1.1 Research Scope
1.2 Market Segmentation by Types of Adrenocortical Carcinoma Treatment
1.3 Market Segmentation by End Users of Adrenocortical Carcinoma Treatment
1.4 Market Dynamics Analysis of Adrenocortical Carcinoma Treatment
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Adrenocortical Carcinoma Treatment Industry
2.1 ArQule
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Adrenocortical Carcinoma Treatment Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 EnGeneIC
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Adrenocortical Carcinoma Treatment Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Exelixis
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Adrenocortical Carcinoma Treatment Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Merck
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Adrenocortical Carcinoma Treatment Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Millendo Therapeutics
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Adrenocortical Carcinoma Treatment Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Orphagen Pharmaceuticals
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Adrenocortical Carcinoma Treatment Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
3 Global Adrenocortical Carcinoma Treatment Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Adrenocortical Carcinoma Treatment by Regions (2018-2023)
3.2 Global Sales Revenue of Adrenocortical Carcinoma Treatment by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Adrenocortical Carcinoma Treatment by Types (2018-2023)
3.4 Global Sales Revenue of Adrenocortical Carcinoma Treatment by End Users (2018-2023)
4 Northern America Adrenocortical Carcinoma Treatment Market Analysis by Countries, Types and End Users
4.1 Northern America Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Adrenocortical Carcinoma Treatment Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
4.5 Canada Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
5 Europe Adrenocortical Carcinoma Treatment Market Analysis by Countries, Types and End Users
5.1 Europe Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Adrenocortical Carcinoma Treatment Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
5.5 France Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
5.6 UK Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
5.7 Italy Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
5.8 Russia Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
5.9 Spain Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
5.10 Netherlands Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
6 Asia Pacific Adrenocortical Carcinoma Treatment Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Adrenocortical Carcinoma Treatment Sales Revenue Analysis by End Users (2018-2023)
6.4 China Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
6.5 Japan Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
6.6 Korea Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
6.7 India Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
6.8 Australia Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
6.9 Indonesia Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
6.10 Vietnam Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
7 Latin America Adrenocortical Carcinoma Treatment Market Analysis by Countries, Types and End Users
7.1 Latin America Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Adrenocortical Carcinoma Treatment Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
7.5 Mexico Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
7.6 Argentina Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
7.7 Colombia Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Adrenocortical Carcinoma Treatment Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Adrenocortical Carcinoma Treatment Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Adrenocortical Carcinoma Treatment Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
8.6 South Africa Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
8.7 Egypt Adrenocortical Carcinoma Treatment Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Adrenocortical Carcinoma Treatment Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Adrenocortical Carcinoma Treatment by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Adrenocortical Carcinoma Treatment by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Adrenocortical Carcinoma Treatment by End Users (2024-2029)
10.4 Global Revenue Forecast of Adrenocortical Carcinoma Treatment by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Adrenocortical Carcinoma Treatment
11.1 Upstream Analysis of Adrenocortical Carcinoma Treatment
11.2 Downstream Major Consumers Analysis of Adrenocortical Carcinoma Treatment
11.3 Major Suppliers of Adrenocortical Carcinoma Treatment with Contact Information
11.4 Supply Chain Relationship Analysis of Adrenocortical Carcinoma Treatment
12 Adrenocortical Carcinoma Treatment New Project Investment Feasibility Analysis
12.1 Adrenocortical Carcinoma Treatment New Project SWOT Analysis
12.2 Adrenocortical Carcinoma Treatment New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Adrenocortical Carcinoma Treatment Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Adrenocortical Carcinoma Treatment
Table End Users of Adrenocortical Carcinoma Treatment
Figure Market Drivers Analysis of Adrenocortical Carcinoma Treatment
Figure Market Challenges Analysis of Adrenocortical Carcinoma Treatment
Figure Market Opportunities Analysis of Adrenocortical Carcinoma Treatment
Table Market Drivers Analysis of Adrenocortical Carcinoma Treatment
Table ArQule Information List
Figure Adrenocortical Carcinoma Treatment Specifications of ArQule
Table Adrenocortical Carcinoma Treatment Revenue (Million USD) and Gross Margin of ArQule (2018-2023)
Figure Adrenocortical Carcinoma Treatment Revenue (Million USD) and Global Market Share of ArQule (2018-2023)
Table EnGeneIC Information List
Figure Adrenocortical Carcinoma Treatment Specifications of EnGeneIC
Table Adrenocortical Carcinoma Treatment Revenue (Million USD) and Gross Margin of EnGeneIC (2018-2023)
Figure Adrenocortical Carcinoma Treatment Revenue (Million USD) and Global Market Share of EnGeneIC (2018-2023)
Table Exelixis Information List
Figure Adrenocortical Carcinoma Treatment Specifications of Exelixis
Table Adrenocortical Carcinoma Treatment Revenue (Million USD) and Gross Margin of Exelixis (2018-2023)
Figure Adrenocortical Carcinoma Treatment Revenue (Million USD) and Global Market Share of Exelixis (2018-2023)
Table Merck Information List
Figure Adrenocortical Carcinoma Treatment Specifications of Merck
Table Adrenocortical Carcinoma Treatment Revenue (Million USD) and Gross Margin of Merck (2018-2023)
Figure Adrenocortical Carcinoma Treatment Revenue (Million USD) and Global Market Share of Merck (2018-2023)
Table Millendo Therapeutics Information List
Figure Adrenocortical Carcinoma Treatment Specifications of Millendo Therapeutics
Table Adrenocortical Carcinoma Treatment Revenue (Million USD) and Gross Margin of Millendo Therapeutics (2018-2023)
Figure Adrenocortical Carcinoma Treatment Revenue (Million USD) and Global Market Share of Millendo Therapeutics (2018-2023)
Table Orphagen Pharmaceuticals Information List
Figure Adrenocortical Carcinoma Treatment Specifications of Orphagen Pharmaceuticals
Table Adrenocortical Carcinoma Treatment Revenue (Million USD) and Gross Margin of Orphagen Pharmaceuticals (2018-2023)
Figure Adrenocortical Carcinoma Treatment Revenue (Million USD) and Global Market Share of Orphagen Pharmaceuticals (2018-2023)
Table Global Revenue (Million USD) of Adrenocortical Carcinoma Treatment by Regions (2018-2023)
Table Global Revenue (Million USD) of Adrenocortical Carcinoma Treatment by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Adrenocortical Carcinoma Treatment by Types (2018-2023)
Table Global Revenue (Million USD) of Adrenocortical Carcinoma Treatment by End Users (2018-2023)
Table Northern America Adrenocortical Carcinoma Treatment Revenue (Million USD) by Countries (2018-2023)
Table Northern America Adrenocortical Carcinoma Treatment Revenue (Million USD) by Types (2018-2023)
Table Northern America Adrenocortical Carcinoma Treatment Revenue (Million USD) by End Users (2018-2023)
Figure United States Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Adrenocortical Carcinoma Treatment Revenue (Million USD) by Countries (2018-2023)
Table Europe Adrenocortical Carcinoma Treatment Revenue (Million USD) by Types (2018-2023)
Table Europe Adrenocortical Carcinoma Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Germany Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Adrenocortical Carcinoma Treatment Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Adrenocortical Carcinoma Treatment Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Adrenocortical Carcinoma Treatment Revenue (Million USD) by End Users (2018-2023)
Figure China Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Adrenocortical Carcinoma Treatment Revenue (Million USD) by Countries (2018-2023)
Table Latin America Adrenocortical Carcinoma Treatment Revenue (Million USD) by Types (2018-2023)
Table Latin America Adrenocortical Carcinoma Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Adrenocortical Carcinoma Treatment Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Adrenocortical Carcinoma Treatment Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Adrenocortical Carcinoma Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Adrenocortical Carcinoma Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Adrenocortical Carcinoma Treatment by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Adrenocortical Carcinoma Treatment by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Adrenocortical Carcinoma Treatment by End Users (2024-2029)
Table Major Consumers with Contact Information of Adrenocortical Carcinoma Treatment
Table Major Suppliers of Adrenocortical Carcinoma Treatment with Contact Information
Figure Supply Chain Relationship Analysis of Adrenocortical Carcinoma Treatment
Table New Project SWOT Analysis of Adrenocortical Carcinoma Treatment
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Adrenocortical Carcinoma Treatment
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Adrenocortical Carcinoma Treatment Industry
Table Part of References List of Adrenocortical Carcinoma Treatment Industry
Table Units of Measurement List
Table Part of Author Details List of Adrenocortical Carcinoma Treatment Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Adrenocortical Carcinoma Treatment industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Adrenocortical Carcinoma Treatment market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Adrenocortical Carcinoma Treatment manufacturers, Adrenocortical Carcinoma Treatment raw material suppliers, Adrenocortical Carcinoma Treatment distributors as well as buyers. The primary sources from the supply side include Adrenocortical Carcinoma Treatment manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Adrenocortical Carcinoma Treatment raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Adrenocortical Carcinoma Treatment industry landscape and trends, Adrenocortical Carcinoma Treatment market dynamics and key issues, Adrenocortical Carcinoma Treatment technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Adrenocortical Carcinoma Treatment competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Adrenocortical Carcinoma Treatment market size and forecast by regions, Adrenocortical Carcinoma Treatment market size and forecast by application, Adrenocortical Carcinoma Treatment market size and forecast by types, Adrenocortical Carcinoma Treatment company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
